Vita Coco Insider: 10,000-Share Exercise and 10,000-Share Sale Reported
Rhea-AI Filing Summary
Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc. (COCO), reported insider activity showing simultaneous option exercise and open-market sales on 09/17/2025. She acquired 10,000 shares at $10.178 per share (Code M) and sold 10,000 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.043, with sale prices ranging from $42.00 to $42.19. After these transactions she beneficially owned 123,666 shares. The filing lists multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including 33,750 currently exercisable shares and several tranches vesting through 2035.
Positive
- Transactions executed under a Rule 10b5-1 plan, which provides an affirmative defense regarding trade timing
- Continued substantial holdings: the reporting person retains 123,666 shares after the transactions, indicating ongoing ownership alignment
- Large vested option pool: 33,750 options are currently exercisable, showing available vested equity
Negative
- Disposition of 10,000 shares at a weighted average price of $42.043 reduced the reporting person’s share count by 10,000
- Concentrated future vesting extends through 2035, which may delay full realization of equity value for the reporting person
Insights
TL;DR: Insider exercised options at low cost and sold an equal number under a 10b5-1 plan, vesting schedule shows multi-year equity compensation.
The exercise at $10.178 and immediate disposition of 10,000 shares at a weighted average of $42.043 indicates capture of intrinsic value from equity compensation. The reporting person still holds substantial option positions and 123,666 shares post-transaction, leaving continued alignment with shareholders. Transactions were executed under a Rule 10b5-1 plan, reducing concerns about timing. For valuation impact, the realized spread per share was roughly $31.865 based on stated prices, but the filing does not report proceeds or tax treatment.
TL;DR: Transactions appear routine and documented; use of 10b5-1 plan supports procedural compliance.
Disclosure shows proper use of an affirmative defense trading plan and the form is signed by an attorney-in-fact, indicating administrative compliance. The mix of fully vested options and long-dated tranches through 2035 reflects standard executive compensation structuring to retain executives. No pledging, transfers to affiliates, or unusual derivative structures are disclosed in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | -- |
| Exercise | Common Stock | 10,000 | $10.178 | $102K |
| Sale | Common Stock | 10,000 | $42.043 | $420K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
